Abstract

Purpose: Gyrate atrophy (GA) of the fundus is a rare, progressive metabolic disease secondary to the deficiency of the pyridoxal phosphate-dependent enzyme, ornithine aminotransferase. GA may lead to cystoid macular edema (CME) resulting from chronic inflammation. We aimed to report a child case with CME secondary to gyrate atrophy. Methods: Herein we presented a GA case treated with posterior sub-Tenon triamcinolone acetonide injection. Results: Optical coherence tomography examination revealed the disappearance of the macular edema that is a vision-threatening complication in GA. Conclusion: The present case showed that the posterior sub-Tenon injection of long acting steroids might be a promising treatment in CME secondary to GA.

Highlights

  • Gyrate atrophy (GA) of the fundus is a rare, progressive metabolic disorder secondary to the deficiency of the pyridoxal phosphate-dependent enzyme, ornithine aminotransferase (OAT) [1]

  • We aimed to present a child with cystoid macular edema (CME) secondary to gyrate atrophy treated with injection of subTenon triamcinolone acetonide (TA)

  • To the best of our knowledge, this is the first case report of CME secondary to GA treated with sub-Tenon TA

Read more

Summary

Introduction

Gyrate atrophy (GA) of the fundus is a rare, progressive metabolic disorder secondary to the deficiency of the pyridoxal phosphate-dependent enzyme, ornithine aminotransferase (OAT) [1]. Deficiency in OAT leads to 10 to 20-fold higher plasma ornithine levels than those of controls [2]. The sharply demarcated, round shaped chorioretinal atrophy with pigmented margins in the peripheral retina is the pathognomonic finding of GA. The patients with GA complain with visual deterioration and loss of night vision due to retinal atrophy, cataract formation, or cystoid macular edema (CME). Imaging provides more information about macular edema in GA [3]. We aimed to present a child with CME secondary to gyrate atrophy treated with injection of subTenon triamcinolone acetonide (TA)

Objectives
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.